A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/1994
12/14/1994	EP0543864B1 Novel vitamin d analogues
12/14/1994	EP0471030B1 Glycoprotein hormone receptor molecules
12/14/1994	EP0382840B1 Aloe compositions and uses thereof
12/14/1994	EP0101681B1 Antibody to a mediator activity composition and its use in a pharmaceutical composition
12/13/1994	US5373022 Salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms
12/13/1994	US5373018 Antagonist to excitory amino acids on N-methyl aspartic acid receptor complex, theraputically effective in treatment of central nervous system disorder
12/13/1994	US5373017 Renin inhibitor
12/13/1994	US5373015 Treating hypertension and congestive heart failure
12/13/1994	US5373007 Pyridooxazinyl or pyridothiazinyl as inhibitors of leukotrienes
12/13/1994	US5373003 1-azabicyclo[3.2.2]nonan-3-amine derivatives
12/13/1994	US5372809 Antigenic matrix metalloproteinase peptides
12/13/1994	CA1333471C Whey protein concentrate as food supplement
12/11/1994	CA2125458A1 Pyrimidine compounds and their use as pharmaceuticals
12/09/1994	CA2125359A1 Pyridazines as interleukin-1.beta.-converting enzyme inhibitors
12/08/1994	WO1994028132A2 Opioid receptors: compositions and methods
12/08/1994	WO1994028025A1 Methods and compositions for inhibiting cd14 mediated cell activation
12/08/1994	WO1994028022A1 Novel protein having avidity with heparin-binding growth factor
12/08/1994	WO1994028016A1 CLONING, EXPRESSION AND USES OF $i(DORSALIN-1)
12/08/1994	WO1994028015A1 Lhrh antagonists
12/08/1994	WO1994027999A1 Bicyclic ether derivatives and their use as 5-lipoxygenase inhibitors
12/08/1994	WO1994027994A1 Piperidine derivatives, their preparation and use
12/08/1994	WO1994027990A1 INDOLE DERIVATIVES AS STEROID 5α-REDUCTASE INHIBITORS
12/08/1994	WO1994027987A1 5-ht4 receptor antagonists
12/08/1994	WO1994027982A1 Use of indolocarbazole derivatives to treat a pathological condition of the prostate
12/08/1994	WO1994027980A1 Substituted oxazolyl compounds for the treatment of inflammation
12/08/1994	WO1994027979A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
12/08/1994	WO1994027968A1 Quinoline derivatives as leukotriene antagonists
12/08/1994	WO1994027965A1 Novel 1-phenylalkanone 5-ht4 receptor ligands
12/08/1994	WO1994027964A1 3-(indol-3-yl) propenoic acid derivatives and as nmda antagonists
12/08/1994	WO1994027961A1 N-alkylthio polyamine derivatives as radioprotective agents
12/08/1994	WO1994027957A1 Compounds which release nitric oxide
12/08/1994	WO1994027954A1 Nitrobenzyl mustard quaternary salts and their use as hypoxia-selective cytotoxic agents
12/08/1994	WO1994027633A1 Bandage for continuous application of biologicals
12/08/1994	WO1994027632A1 Cell growth regulators
12/08/1994	WO1994027614A1 Use of lignan derivatives for the preparation of pharmaceutical compositions for the treatment of states of amyloidosis
12/08/1994	WO1994027603A1 Alkaline and acid phosphatase inhibitors in treatment of neurological disorders
12/08/1994	WO1994027594A2 Stable copper(i) complexes and methods related thereto
12/08/1994	WO1994027592A1 Use of dihydroliponic acid as an ophthalmologic agent and for the suppression of incompatability reactions at the interfaces between implants and living body tissue
12/08/1994	WO1994027591A1 Therapeutic substituted guanidines
12/08/1994	WO1994027590A1 New procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis
12/08/1994	WO1994027586A1 Inhibition of hair growth
12/08/1994	WO1994027585A1 Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders
12/08/1994	WO1994027583A2 Apoptosis inhibitors for treating neurodegenerative diseases
12/08/1994	WO1994027563A1 Inhibition of hair growth
12/08/1994	WO1994027426A1 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases
12/08/1994	WO1994012165A3 Enzyme inhibitors
12/08/1994	CA2163966A1 Alkaline and acid phosphatase inhibitors in treatment of neurological disorders
12/08/1994	CA2163887A1 Use of lignan derivatives for the preparation of pharmaceutical compositions for the treatment of states of amyloidosis
12/08/1994	CA2163640A1 Stable copper (i) complexes and their use as active therapeutic substances
12/08/1994	CA2163638A1 Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders
12/08/1994	CA2163372A1 5-ht4 receptor antagonists
12/08/1994	CA2163350A1 Opioid receptors: compositions and methods
12/08/1994	CA2163225A1 Lhrh antagonists
12/08/1994	CA2162467A1 Use of dihydroliponic acid as an ophthalmologic agent and for the suppression of incompatability reactions at the interfaces between implants and living body tissue
12/08/1994	CA2161979A1 Cloning, expression and uses of dorsalin-1
12/08/1994	CA2161769A1 Substituted oxazolyl compounds for the treatment of inflammation
12/08/1994	CA2125077A1 Imidazopyridine
12/07/1994	EP0627432A1 6-Piperazinyl-1H-pyrazolo [3,4-b]pyridine-3-carboxylic Acids, Esters, Amides andrelated compounds, a process for their preparation and their use as medicaments
12/07/1994	EP0627400A1 Aromatic acetylcholinesterase inhibitors
12/07/1994	EP0627221A2 Substance P antagonists for the treatment of emesis
12/07/1994	EP0627002A1 Cloning and expression of humanized monoclonal antibodies against human interleukin-4
12/07/1994	EP0626973A1 Phenylalanine analogs of bombesin
12/07/1994	EP0626969A1 CoA-IT AND PAF INHIBITORS
12/07/1994	EP0626957A1 Styril derivatives and processes for their preparation
12/07/1994	EP0626940A1 Substituted phenylethenyl compounds having retinoid-like biological activity
12/07/1994	EP0626849A1 Brofaromine as an agent for treating post-traumatic stress
12/07/1994	EP0612211A4 Alteration of rate and character of hair growth.
12/07/1994	CN1026892C New amino acid derivatives, a process for the preparation thereof and pharmaceutical composition comprising the same
12/07/1994	CN1026862C Process for producting of dry bioactive recombinant growth hormones
12/06/1994	US5371226 2-oxoquinoline derivatives
12/06/1994	US5371204 Interleukins
12/06/1994	US5371191 Osteoinductive protein mixtures and purification processes
12/06/1994	US5371108 Tear film over ocular surface comprising layer of gel of oil and wax
12/06/1994	US5371098 Use of oxazole compounds to treat osteoporosis
12/06/1994	US5371097 Antiulcer agents
12/06/1994	US5371094 Azaheterocyclylmethyl-chromans for treating axiety
12/06/1994	US5371077 Side chain derivatized 15-oxygenated sterols, methods of using them and a process for preparing them
12/06/1994	US5371074 Use of saccharin derivatives as proteolytic enzyme inhibitors
12/06/1994	US5370880 Pharmaceutical formulations containing acrivastine
12/06/1994	CA2005072C Antispasmodic agent comprising creosote or its phenol derivative
12/06/1994	CA1333397C Fluorinated arachidonic acid derivatives
12/04/1994	CA2125021A1 Alpha-heteroaryloxymethyl ketones as interleukin-1 beta converting enzyme inhibitors
12/01/1994	DE4345199A1 Use of dihydrolipoic acid
11/1994
11/30/1994	EP0626389A1 Recombinant antibodies specific for TNF-alpha
11/30/1994	EP0626378A1 Saccharin derivative proteolytic enzyme inhibitors
11/30/1994	EP0625991A1 Improved alpha interferon composition and method for its production from human peripheral blood leukocytes
11/30/1994	EP0625989A1 Dna sequences encoding novel growth/differentiation factors
11/30/1994	EP0625987A1 Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
11/30/1994	EP0625977A1 Piperazine derivatives as 5-ht1a antagonists
11/30/1994	EP0625903A1 Topical antiglaucoma compositions comprising carbonic anhydrase inhibitors and beta-blockers
11/30/1994	EP0531410B1 (+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(fluorophenyl)ethyl]-4-piperidinemethanol
11/30/1994	EP0526488B1 Benzylphosphonic acid tyrosine kinase inhibitors
11/30/1994	EP0518904B1 S-(2-thenoyl)-thiolactic acid derivative having pharmacological activity
11/30/1994	EP0449819B1 Structured lipid containing dairy fat
11/30/1994	EP0427799B1 Method and compounds for aica riboside delivery and for lowering blood glucose
11/30/1994	EP0422164B1 Large multivalent immunogen
11/30/1994	EP0381750B1 Method for treating and preventing loss of bone mass
11/30/1994	CN1095714A Phthalazinone derivatives
11/30/1994	CN1095713A Process for making compounds
11/30/1994	CN1095712A Compounds

1 ... 1416 1417 1418 1419 1420 1421 1422 1423 1424 1425 1426 1427 1428 1429 1430 1431 1432 1433 1434 1435 1436 ... 1564